SCHEMBL4898877

SCHEMBL4898877

CCCCCC(Cl)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL420467 0.97 TSHR (0.46)
SCHEMBL4896810 0.97 TSHR (0.46)
SCHEMBL1412105 0.97 TSHR (0.46)
SCHEMBL19462782 0.97 TSHR (0.46)
SCHEMBL2369634 0.97 TSHR (0.46)
SCHEMBL11402880 0.97 TSHR (0.46)
SCHEMBL9067354 0.95 TSHR (0.43)
SCHEMBL2479083 0.92
SCHEMBL5404425 0.92
Ammonia Solution, Strong SCHEMBL9013083 0.89 TSHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265875-A4 PROCESS FOR PREPARING PURE CRYSTALLINE LORAZEPAM TEVA PHARMA (IL) 2003-07-09 EP claimed
EP-1265875-A2 PROCESS FOR PREPARING PURE CRYSTALLINE LORAZEPAM TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2002-12-18 EP claimed
US-6350870-B2 Process for preparing pure crystalline lorazepam TEVA PHARMACEUTICAL INDUSTREIS, LTD. (IL) 2002-02-26 US claimed
US-20010039340-A1 Process for preparing pure crystalline lorazepam TEVA PHARMACEUTICALS USA, INC. 2001-11-08 US claimed
WO-2001066062-A2 PROCESS FOR PREPARING PURE CRYSTALLINE LORAZEPAM TEVA PHARMAQCEUTICAL INDUSTRIES LTD. (IL) 2001-09-13 WO claimed
CN-119219824-A Crosslinked polymer and preparation method and application thereof 中国石油化工股份有限公司 2024-12-31 CN disclosed
CN-119219840-A Crosslinked polymer and preparation method and application thereof 中国石油化工股份有限公司 2024-12-31 CN disclosed
CN-116063345-B Phosphonic acid group monomer and preparation method thereof 中国石油化工股份有限公司 2024-08-06 CN disclosed
CN-116063626-B Anti-calcium shrinkage and expansion agent and preparation method and application thereof 中国石油化工股份有限公司 2024-05-07 CN disclosed
CN-116064016-B Scale inhibition anti-swelling shrinkage swelling agent and preparation method and application thereof 中国石油化工股份有限公司 2024-04-05 CN disclosed
CN-116063345-A Phosphonic acid group monomer and preparation method thereof 中国石油化工股份有限公司 2023-05-05 CN disclosed
CN-116063626-A Anti-calcium shrinkage and expansion agent and preparation method and application thereof 中国石油化工股份有限公司 2023-05-05 CN disclosed
EP-0008112-A1 Process for the preparation of glycidyl esters of aromatic polycarboxylic acids BAYER AG (DE) 1980-02-20 EP disclosed
EP-0008111-A1 Process for the preparation of glycidyl esters of cycloaliphatic polycarboxylic acids BAYER AG (DE) 1980-02-20 EP disclosed
EP-0008115-A1 Process for the preparation of glycidyl esters of fumaric acid BAYER AG (DE) 1980-02-20 EP disclosed
EP-0002710-A1 Process for the preparation of 5-(oxiranylmethyl)-1.3-benzodioxole BAYER AG (DE) 1979-07-11 EP disclosed
EP-0000554-A1 Process for the preparation of oxiranes substituted by halogen alkyl BAYER AG (DE) 1979-02-07 EP disclosed
EP-0000534-A1 Process for the preparation of vinyl oxiranes BAYER AG (DE) 1979-02-07 EP disclosed
EP-0000535-A1 Process for the preparation of vinyl oxiranes substituted by halogen BAYER AG (DE) 1979-02-07 EP disclosed
US-4043943-A Process for producing a mixed oxide of vanadium and phosphorus having an improved intrinsic surface area CHEVRON RESEARCH COMPANY (US) 1977-08-23 US disclosed